Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy

Table 3

Detection rate MRI/US fusion targeted biopsy by size of ROI ().

Lesion size	Freq.	Any PCa	Sign PCa
		MRI/US Fusion targeted biopsy
<5 mm	22	11 (50%)	7 (32%)
5–9 mm	93	39 (42%)	26 (28%)
≥10 mm	45	28 (62%)	25 (56%)

Freq. = frequency, PCa = prostate cancer, Sign = significant, and ROI = region of interest.